MAT treats both opioid and alcohol addiction, but the details differ by substance. For opioids, you’ll use buprenorphine, methadone, or naltrexone to suppress withdrawal, reduce cravings, and lower overdose risk, often as long-term maintenance lasting months to years. For alcohol, you’ll use naltrexone, acamprosate, or disulfiram to curb heavy drinking or support abstinence after detox, sometimes only temporarily. Counseling stays essential either way. Keep going to see how your right approach gets matched.
Key Takeaways
- Opioid MAT uses buprenorphine, methadone, or naltrexone, while alcohol MAT uses naltrexone, acamprosate, or disulfiram.
- Opioid MAT aims to suppress withdrawal, reduce cravings, and lower overdose risk through long-term maintenance lasting months to years.
- Alcohol MAT focuses on reducing heavy drinking or maintaining abstinence after detox, often used temporarily or for severe cases.
- Naltrexone treats both disorders, but its purpose shifts: blocking opioid euphoria versus reducing alcohol’s reward-driven cravings.
- Both approaches require counseling and behavioral therapy alongside medication, with choice based on diagnosis, withdrawal risk, and recovery goals.
How MAT is used for opioids
Medication-assisted treatment for opioid use disorder pairs an FDA-approved medication with counseling and behavioral therapy to reduce withdrawal symptoms, cravings, and relapse risk. This approach, often called MOUD, is the standard of care, backed by unusually strong evidence. Medication isn’t an optional add-on. You’ve got three main options. Buprenorphine, a partial opioid agonist, eases withdrawal and cravings while its ceiling effect limits respiratory depression. Methadone, a full agonist, is dispensed through licensed opioid treatment programs, creating a more regulated care pathway. Naltrexone blocks opioid receptors, preventing euphoria. Buprenorphine and methadone are the strongest first-line choices. Your goals here center on stabilization, withdrawal suppression, craving reduction, and lowering overdose risk. Expect this to run long-term, often months to years, as ongoing maintenance rather than a brief intervention.
How MAT is used for alcohol
MAT for alcohol use disorder pairs medication with counseling and behavioral therapy, using naltrexone, acamprosate, or disulfiram to reduce heavy drinking or support abstinence. Each drug works differently. Unlike opioid maintenance, alcohol medications often follow detox and may be used more temporarily. They’re commonly prescribed in outpatient medical settings, yet they’re badly underused despite proven benefits.
| Medication | How It Works | Primary Goal |
|---|---|---|
| Naltrexone | Blocks opioid receptors tied to reward | Reduces cravings |
| Acamprosate | Restores brain balance after drinking | Supports abstinence |
| Disulfiram | Triggers unpleasant reaction with alcohol | Deters drinking |
Keep in mind, none of these treat acute withdrawal, which can require emergency or inpatient care.
The medications differ by substance
Opioid treatment draws from a different set of medications than alcohol treatment. For opioid use disorder, you’ll encounter buprenorphine, methadone, and naltrexone. Buprenorphine, a partial opioid agonist, eases withdrawal and cravings while offering a ceiling effect on respiratory depression. Methadone, a full opioid agonist, gets dispensed through licensed opioid treatment programs. Naltrexone blocks opioid receptors, preventing euphoria. Buprenorphine and methadone stand as the strongest evidence-based first-line options. Alcohol treatment, by contrast, relies on naltrexone, acamprosate, and disulfiram.
Naltrexone is the one medication used for both conditions, though its purpose shifts. In alcohol treatment, it reduces reward and cravings by blocking opioid receptors involved in reinforcement. The overlap is limited, so your medication choice depends directly on which substance use disorder you’re treating.
How goals and timelines differ
Goals and timelines differ because the two disorders present different clinical risks. With opioid use disorder, you’ll focus on stabilization, withdrawal suppression, craving reduction, and lowering overdose risk. With alcohol use disorder, you’ll aim to reduce heavy drinking or maintain abstinence after detoxification, often reserving medication for severe cases or repeated relapses.
Timelines differ too. Opioid MAT is commonly a longer-term maintenance strategy, continuing for months to years. If you’re prescribed methadone, you’ll receive it through a licensed opioid treatment program, creating a more regulated pathway. Alcohol-use medications are used more temporarily in some plans and are typically prescribed in outpatient settings.
What stays the same
The core treatment model stays the same across both disorders. Whether you’re treating opioid or alcohol use disorder, MAT combines FDA-approved medication with counseling and behavioral therapy. The framework doesn’t change. Medication supports recovery while therapy addresses the behavioral components of addiction.
Across both conditions, you’ll find these consistent elements:
- Medication plus therapy. You pair an FDA-approved medication with counseling and behavioral support, never medication alone.
- Symptom-focused goals. Treatment targets withdrawal symptoms, cravings, and relapse risk to strengthen recovery behaviors.
- Individualized selection. You base treatment choices on diagnosis, withdrawal risk, pregnancy status, relapse history, and recovery goals.
Naltrexone even bridges both disorders, blocking opioid receptors to reduce reward and cravings. The medications differ, but the evidence-based structure remains constant throughout.
Choosing the right approach
Choosing the right approach depends on your diagnosis, withdrawal risk, pregnancy status, relapse history, and recovery goals. For opioid use disorder, buprenorphine and methadone are first-line options with strong evidence, prioritizing stabilization, withdrawal suppression, craving reduction, and overdose-risk reduction. If you’re pregnant or need a regulated care pathway, methadone through a licensed program may fit your needs.
For alcohol use disorder, you’ll typically start naltrexone, acamprosate, or disulfiram after detox, often reserved for severe AUD or multiple relapses. Your goal shapes the choice: reducing heavy drinking or maintaining abstinence. Remember, none of these treat acute alcohol withdrawal, which can require emergency care.
Work with your provider to match medication, counseling, and behavioral therapy to your specific clinical situation.
Getting matched to treatment
Getting matched to the right treatment starts with an accurate diagnosis and a clear picture of your clinical situation. Your provider weighs several factors before selecting a medication and care setting, since opioid and alcohol use disorders follow different treatment pathways.
Treatment selection depends on:
- Your diagnosis and withdrawal risk, opioid use disorder often needs stabilization and withdrawal suppression, while alcohol treatment usually follows detox.
- Your relapse history and severity, alcohol medications are often reserved for severe AUD or multiple relapses.
- Your pregnancy status and recovery goals, these shape whether you’ll aim for abstinence or reduced heavy drinking.
If you’ve got opioid use disorder, expect longer-term maintenance with buprenorphine or methadone. For alcohol use disorder, you’ll likely receive naltrexone, acamprosate, or disulfiram.
Not Sure Which MAT Is Right for You? One Call Sorts It Out.
The medications that work for opioid addiction aren’t the ones used for alcohol, and the right fit depends on what you’re treating and where your body is. Simonds Recovery Centers in Granada Hills builds medication-assisted treatment around that, whether it’s for opioid use or alcohol, paired with the therapy that makes it hold.
Call (833) 781-8338 now or verify your insurance. Confidential, seven days a week.
Frequently Asked Questions
Does insurance typically cover MAT for opioid or alcohol addiction?
Often, yes. Under federal parity rules, most plans and Medicaid cover medication-assisted treatment for opioid and alcohol use disorders, though the specific medications, prior-authorization requirements, and copays vary by plan. Verify coverage directly with your insurer, and ask the treatment program to help. It’s worth pushing on this, because alcohol-use medications in particular are badly underused, with only a small share of eligible patients ever receiving them. Ask your provider about medication options and confirm what your plan covers.
Can I take MAT medications while pregnant or breastfeeding?
Pregnancy directly shapes treatment selection. For opioid use disorder, buprenorphine and methadone are commonly used during pregnancy to suppress withdrawal and reduce relapse and overdose risk, with close medical supervision throughout. Alcohol-use medications call for more caution, since safety data differ across them. Don’t start or stop any MAT medication on your own. Talk with your prescriber, who will weigh your history, diagnosis, and recovery goals against what’s safest for you and your baby.
Are there side effects associated with MAT medications?
Yes. Buprenorphine and methadone can cause drowsiness, constipation, or respiratory depression, and methadone carries overdose risk if misused. Naltrexone can affect the liver and will trigger withdrawal if you’re still using opioids. For alcohol use disorder, acamprosate may cause diarrhea, while disulfiram produces a deliberately unpleasant reaction if you drink. Discuss your medical history with your provider, since side effects vary by medication and by person.
Can MAT medications be used together or combined?
Sometimes, depending on your diagnosis and goals. You wouldn’t combine buprenorphine and methadone, since both act on opioid receptors. Naltrexone can’t be used with opioid agonists, because it blocks their effect and would precipitate withdrawal. For alcohol use disorder, medications like naltrexone or acamprosate are often paired with behavioral therapy rather than with each other. Your provider will choose based on your withdrawal risk, relapse history, and recovery needs.
Is MAT addictive, and will I become dependent on it?
It’s a fair concern, and the distinction matters. Methadone and buprenorphine are opioids, so you can develop physical dependence, meaning you’d have withdrawal if you stopped abruptly. That’s different from addiction, which involves compulsive use and harm despite consequences. Naltrexone, acamprosate, and disulfiram aren’t addictive at all. Under proper supervision, these medications stabilize recovery rather than fuel it, and when the time is right, you and your provider can taper safely.